Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Different γδ T cell types have unique roles in causing alopecia areata.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

PDCD4 is important for controlling skin cell growth and healing.

The new Hairless R/J mice model improves imaging for tumor monitoring and cancer therapy evaluation.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

CD98hc's role in skin health decreases with age.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Keratins 8 and 14 can help identify and diagnose benign skin tumors.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.